VaramirStart free · no cardSign in
AMRX as of Oct 31 · 16:54 ET
AMRXNasdaqPharmaceutical Preparations

Amneal Pharmaceuticals, Inc. · Brief

Next report

3 days

Nov 3 · before openconfirmedQ3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±15.5%
avg realized
±2.8%
May 2 '25±12.1%▲+2.97%×0.25
Aug 5 '25±29.1%▲+2.14%×0.07
Q3 FY25±10.7%▼−4.12%×0.38
Jan 13 '26±12.4%▼−0.08%×0.01
Feb 27 '26±12.6%▼−4.69%×0.37
Q1 FY26±21.3%▼−1.54%×0.07
May 7 '26±10.1%▼−3.79%×0.38
Q2 FY26±15.6%▼−3.14%×0.20
quarterimplied−30%0+30%realized×
Q2 FY26±15.6%▼−3.14%×0.20
May '26±10.1%▼−3.79%×0.38
Q1 FY26±21.3%▼−1.54%×0.07
Feb '26±12.6%▼−4.69%×0.37
Jan '26±12.4%▼−0.08%×0.01
Q3 FY25±10.7%▼−4.12%×0.38
2 older reports
Aug '25±29.1%▲+2.14%×0.07
May '25±12.1%▲+2.97%×0.25
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · confirmed

Bull2 of 3

308managers reporting a position in the latest quarter13F · Jun 30 '26
+3.31%change in shares held by the largest reporting managers13F · Jun 30 '26

Bear2 of 4

25.00%revenue share from the largest disclosed customerSEC filings
8 of 8recent reports below options implied rangesEarnings history
AI captions · Oct 12 '26once per report · top 2 per case

Linked exposure

AMRX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±17.2% into Nov 3 earnings (Oct 21 close).Source
Oct 8report dateEarnings date confirmed: Nov 3, before open.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.